CRISPR Based Technologies and Bio-products

Genome piece of writing and also the utilization of CRISPR based technologies are expected to revolutionize the assembly of succeeding generation of bio product. DCB12 will concentrate on the foremost recent developments among the employment of CRISPR/Cas9 and different CRISPR based technologies in relevance the event and production of biopharmaceuticals, biochemical, agricultural crops and travel applications. The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.

    Related Conference of CRISPR Based Technologies and Bio-products

    October 17-18, 2022

    21st International Conference on Structural Biology

    Barcelona, Spain
    November 15-16, 2022

    3rd Experts Meeting on Plant, Cellular and Molecular Biology

    Budapest, Hungary
    November 21-22, 2022

    4th Annual summit on Cell Signaling and Cancer Therapy

    Montreal, Canada
    May 03-04, 2023

    16th World Congress on Stem Cell Research

    Paris, France
    May 03-04, 2023

    Global Conference on Cell and Gene Therapy

    Paris, France

    CRISPR Based Technologies and Bio-products Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in